Asia Pac Allergy:2016年墨尔本风暴性哮喘流行分析:哮喘、鼻炎和其他过敏症

2017-11-10 AlexYang MedSci原创

2016年11月21日,墨尔本经历了风暴性哮喘流行。尽管在以前的文献中有所报道,风险因素和自然史仍旧没有完全阐释。最近,有研究人员跟踪调查了在流行期间,在他们的急诊室(EDs)就医的病人,并且对他们以往的哮喘、鼻炎和过敏症进行了评估。研究人员回顾了对在风暴事件48小时内的所有呼吸道表现的ED记录,并且包括了急性哮喘的病人。另外,研究人员还围绕哮喘诊断、未诊断哮喘症状和鼻炎程度设计了标准化的调查问卷

2016年11月21日,墨尔本经历了风暴性哮喘流行。尽管在以前的文献中有所报道,风险因素和自然史仍旧没有完全阐释。最近,有研究人员跟踪调查了在流行期间,在他们的急诊室(EDs)就医的病人,并且对他们以往的哮喘、鼻炎和过敏症进行了评估。

研究人员回顾了对在风暴事件48小时内的所有呼吸道表现的ED记录,并且包括了急性哮喘的病人。另外,研究人员还围绕哮喘诊断、未诊断哮喘症状和鼻炎程度设计了标准化的调查问卷,并且在事件发生30天内利用电话与病人联系。

研究总共包括了344名病人;其中263名病人能够联系上并且完成了电话或者邮件形式的调查问卷。平均年龄为32.7±19.2岁(范围为6个月到87岁,25%的病人小于18岁),男性占58%。研究发现,哮喘诊断过的占42%(n=111),没有诊断过的占58%(n=158)。在那些没有哮喘诊断的参与者中,53%很可能具有哮喘。总之,鼻炎流行度为88%,其中72%为中度或者是重度,并且51%(n=133)报道具有草花粉过敏历史。最后,研究人员指出,他们的研究强调了特异反应性和鼻炎作为流行性风暴哮喘风险因素的重要性。对未诊断哮喘和哮喘即鼻炎实施治疗是很重要的。

原始出处:

Rangamuwa KB, Young AC, Thien F et al. An epidemic of thunderstorm asthma in Melbourne 2016: asthma, rhinitis, and other previous allergies. Asia Pac Allergy. Oct 2017.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1780078, encodeId=1f861e8007885, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2860, encryptionId=10d62860dd, topicName=ASIA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Mon Mar 26 21:28:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928249, encodeId=1f7e1928249b6, content=<a href='/topic/show?id=9ee14234417' target=_blank style='color:#2F92EE;'>#墨尔本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42344, encryptionId=9ee14234417, topicName=墨尔本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Sat Oct 20 12:28:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329031, encodeId=24a8132903132, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sun Nov 12 11:28:00 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516446, encodeId=5ca1151644683, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Sun Nov 12 11:28:00 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260357, encodeId=c6ad26035e8a, content=学习了.好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Nov 10 21:42:32 CST 2017, time=2017-11-10, status=1, ipAttribution=)]
    2018-03-26 luwei00
  2. [GetPortalCommentsPageByObjectIdResponse(id=1780078, encodeId=1f861e8007885, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2860, encryptionId=10d62860dd, topicName=ASIA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Mon Mar 26 21:28:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928249, encodeId=1f7e1928249b6, content=<a href='/topic/show?id=9ee14234417' target=_blank style='color:#2F92EE;'>#墨尔本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42344, encryptionId=9ee14234417, topicName=墨尔本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Sat Oct 20 12:28:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329031, encodeId=24a8132903132, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sun Nov 12 11:28:00 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516446, encodeId=5ca1151644683, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Sun Nov 12 11:28:00 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260357, encodeId=c6ad26035e8a, content=学习了.好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Nov 10 21:42:32 CST 2017, time=2017-11-10, status=1, ipAttribution=)]
    2018-10-20 mfx799
  3. [GetPortalCommentsPageByObjectIdResponse(id=1780078, encodeId=1f861e8007885, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2860, encryptionId=10d62860dd, topicName=ASIA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Mon Mar 26 21:28:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928249, encodeId=1f7e1928249b6, content=<a href='/topic/show?id=9ee14234417' target=_blank style='color:#2F92EE;'>#墨尔本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42344, encryptionId=9ee14234417, topicName=墨尔本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Sat Oct 20 12:28:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329031, encodeId=24a8132903132, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sun Nov 12 11:28:00 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516446, encodeId=5ca1151644683, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Sun Nov 12 11:28:00 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260357, encodeId=c6ad26035e8a, content=学习了.好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Nov 10 21:42:32 CST 2017, time=2017-11-10, status=1, ipAttribution=)]
    2017-11-12 膀胱癌
  4. [GetPortalCommentsPageByObjectIdResponse(id=1780078, encodeId=1f861e8007885, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2860, encryptionId=10d62860dd, topicName=ASIA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Mon Mar 26 21:28:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928249, encodeId=1f7e1928249b6, content=<a href='/topic/show?id=9ee14234417' target=_blank style='color:#2F92EE;'>#墨尔本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42344, encryptionId=9ee14234417, topicName=墨尔本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Sat Oct 20 12:28:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329031, encodeId=24a8132903132, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sun Nov 12 11:28:00 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516446, encodeId=5ca1151644683, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Sun Nov 12 11:28:00 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260357, encodeId=c6ad26035e8a, content=学习了.好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Nov 10 21:42:32 CST 2017, time=2017-11-10, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1780078, encodeId=1f861e8007885, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2860, encryptionId=10d62860dd, topicName=ASIA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Mon Mar 26 21:28:00 CST 2018, time=2018-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928249, encodeId=1f7e1928249b6, content=<a href='/topic/show?id=9ee14234417' target=_blank style='color:#2F92EE;'>#墨尔本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42344, encryptionId=9ee14234417, topicName=墨尔本)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6411176, createdName=mfx799, createdTime=Sat Oct 20 12:28:00 CST 2018, time=2018-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329031, encodeId=24a8132903132, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sun Nov 12 11:28:00 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516446, encodeId=5ca1151644683, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Sun Nov 12 11:28:00 CST 2017, time=2017-11-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=260357, encodeId=c6ad26035e8a, content=学习了.好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Fri Nov 10 21:42:32 CST 2017, time=2017-11-10, status=1, ipAttribution=)]
    2017-11-10 1ddf0692m34(暂无匿称)

    学习了.好文章

    0

相关资讯

盘点:哮喘近期重要研究进展汇总

自上世纪80年代末以来,全球哮喘死亡率下降的趋势可能已经停滞。据估测,我国约有3000万哮喘患者,但根据我国哮喘流行病学调查的最新数据,仅有四成(40.5%)患者达到控制,这里梅斯小编整理了近期关于哮喘的重要研究进展与大家一同分享。【1】螨虫防渗被罩可以预防儿童哮喘加重接触过敏原的致敏性哮喘患者与病毒之间相互作用增加哮喘发作的风险。Am J Resp Crit Care发表的一项研究评估了屋尘螨虫

Eur Respir J:交通空气污染暴露与中年人哮喘风险增加和肺功能不良有关!

TRAP暴露与中年人的哮息和哮喘风险增加以及肺功能降低相关。GSTT1基因的相互作用表明缺乏抗氧化机制可能在这些不良健康效应中发挥着重要作用。

Chest:医学互联网对哮喘的监控意义重大!

近期,一项发表在杂志Chest上的研究进行了基于互联网的监测系统(IBS)调查,以便在严重哮喘研究计划(SARP)中监测哮喘患者的症状和恶化情况。此项研究的目标是评估IBS调查工具的依从性,并探索IBS工具的数据如何帮助了解哮喘表型。研究者们邀请了SARP III队列(n = 528)中的成人受试者完成月度IBS哮喘控制调查,并比较了参与IBS调查工具的受试者的特征。参与IBS(IBS +)的受试

Thorax:早期呼吸道感染对学龄期肺功能和哮喘的影响!

由此可见,3岁以前呼吸道感染与学龄儿童肺功能下降与哮喘发生风险增加密切相关。

PLOS ONE:呼吸道微生物影响哮喘

已有的研究表明,哮喘严重程度的差异可能与气道炎症有关。人们已经把下呼吸道微生物菌群和临床表征联系在了一起,比如气道阻塞,症状控制,和对皮质类固醇的反应。

Lancet Respir Med:科学研究发现,维生素D的又一个神奇的作用!

研究表明,除了标准的哮喘药物外,服用口服维生素D还可以使哮喘发作的风险减半。